title: Pulmonary arterial hypertension exacerbated by ruxolitinib.
authors: Pulmonary Hypertension, University Hospitals Bristol NHS Foundation Trust, Bristol Royal Infirmary, London andrew.low@uhbristol.nhs.uk.
authors: Andrew T
authors: AT
authors: Low
authors: National Pulmonary Hypertension Service, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London.
authors: Luke
authors: L
authors: Howard
authors: Department of Haematology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
authors: Claire
authors: C
authors: Harrison
authors: Pulmonary Hypertension, University Hospitals Bristol NHS Foundation Trust, Bristol Royal Infirmary, London.
authors: Robert M R
authors: RM
authors: Tulloh
mesh_terms: D018450:Disease Progression; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000139:chemically induced* / Q000175:diagnosis*; D053612:Janus Kinases / Q000037:antagonists & inhibitors*; D008875:Middle Aged; D009570:Nitriles; D011720:Pyrazoles / Q000009:adverse effects*; D011743:Pyrimidines
chemical_list: D009570:Nitriles; D011720:Pyrazoles; D011743:Pyrimidines; C540383:ruxolitinib; D053612:Janus Kinases
keywords: JAK inhibitor; Ruxolitinib; drug induced pulmonary arterial hypertension; myelofibrosis